¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"membrane attack complex inhibitor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® transient ischemic attack(TIA) ÇÑ±Û Àϰú¼ºÇãÇ÷¹ßÀÛ
¼³¸í   
  ³úÇ÷°ü Æó¼â¿¡ ÀÇÇÑ Àϰú¼ºÀÇ ½Ç½Å, µÎÅë, ½Ã·Â»ó½Ç µîÀÇ Áõ¼¼¸¦ º¸À̴ »óÅ·Π24½Ã°£ À̳»¿¡ ¸ðµç Áõ»óÀ̠ȸº¹µÇ´Â °æ¿ì¸¦ ¸»ÇÑ´Ù. ÈÄ¿¡ ¿µ±¸ÀûÀΠ³úÇãÇ÷ Áï ³ú°æ»öÁõÀÌ ¿Ã °¡´É¼ºÀÌ ¸Å¿ì ³ô¾ÆÁø´Ù.
¿µ¹® arachnoid membrane ÇÑ±Û °Å¹Ì¸·
¼³¸í   
  ³ú¸·À» ÀÌ·ç´Â ¸·ÀÇ Çϳª. ³ú¸·À̶õ ³ú¸¦ ½Î°í Àִ ¸·À¸·Î Å©°Ô 3°³ÀÇ ¸·À¸·Î ÀÌ·ç¾îÁ® ÀÖ´Ù. °¡Àå¹Ù±ù¿¡ Àִ ¸·À» °æÁú¸·(dura mater)À̶ó°í ÇÑ´Ù. ±× ´ÙÀ½ÀÇ ¸·ÀÌ °Å¹Ì¸·ÀÌ´Ù. ±×¸®°í ³ú¿¡ °­ÇϰԠ¹ÐÂøµÇ¾î Àִ °¡Àå ¾ÈÂÊÀÇ ¸·ÀÌ ¿¬¸·(pia mater)ÀÌ´Ù. °Å¹Ì¸·Àº ¿¬¸·°ú °Å¹ÌÁÙ°°Àº ±¸Á¶¹°·Î ¾ÆÁÖ ´À½¼ÇϰԠºÎÂøµÇ¾î ÀÖ´Ù. ±×·¡¼­ °Å¹Ì¸· ¹Ø¿¡´Â °ø°£ÀÌ ÀÖ´Ù. ÀÌ °ø°£À» °Å¹Ì¸·¹Ø°ø°­À̶ó°í Çϰí ÀÌ °ø°£Àº ¸¼Àº ¾×ü·Î Â÷ ÀÖ´Ù. ÀÌ ¾×ü¸¦ ³úô¼ö¾×(cerebrospinal fluid)À̶ó°í ÇÑ´Ù.
  
  °Å¹Ì¸·
  
  
¿µ¹® basement membrane ÇÑ±Û ¹Ù´Ú¸·, ±âÀú¸·
¼³¸í   
  »óÇǼ¼Æ÷, ±ÙÀ°¼¼Æ÷, ½Å°æÁ¶Á÷°ú ±×°ÍµéÀÇ ¹Ù±ùÂÊ °áÇÕÁ¶Á÷ÀÇ °æ°è¿¡ Àִ Á¡¾×´Ù´çÁú°ú ´Ü¹éÁú·Î ±¸¼ºµÈ ¾ãÀº ¸·. ±âÃʸ· ¶Ç´Â °æ°è¸·À̶ó°íµµ ÇÑ´Ù. µÎ²²´Â 50~80nmÀÌ´Ù. ±âÀú¸·Àº 20~30nm °£°ÝÀ¸·Î ´Ã¾î¼± Á·¼¼Æ÷·Î µÈ »óÇǼ¼Æ÷ÀÇ 3ÃþÀ¸·Î µÇ¾î ÀÖ°í, ºÐÀÚ·® 40,000~60,000ÀÇ ¹°ÁúÀ» Åõ°úÇÒ ¼ö ÀÖ°Ô ÇÑ´Ù. ¶ÇÇѠǥÇǿ͠ÁøÇÇÀÇ °æ°è·Î ¿µ¾çÀ» °ø±ÞÇϴ ±âÁö ¿ªÇÒÀ» ÇÑ´Ù. ÁַΠ¼¶À¯¸¦ Æ÷ÇÔÇÏ¿© ´Ù´ç·ù·Î µÇ¾î Àִµ¥, ÇöÀúÇϰԠ¹ß´ÞµÇ¾î Àִ ºÎºÐ°ú ±×·¸Áö ¾ÊÀº ºÎºÐÀÌ ÀÖ´Ù. ºñÁ¡¸·¿¡¼­´Â Á¡¸·»óÇÇÀÇ ¹Ø¿¡ ¹ß´ÞÇÑ ±âÀú¸·ÀÌ ÀÖ´Ù. ÀÌ ¸· À§¿¡ Ã»°¢¼ö¿ë¼¼Æ÷ÀΠÅм¼Æ÷¸¦ °®´Â ÄÚ¸£Æ¼±â°üÀÌ Á¸ÀçÇÑ´Ù. ±âÀú¸·Àº ÀüÁ¦°¡ À½Àü±â ¼ºÁúÀ» °¡Áö°í À־çÀü±â¸¦ °¡Áø ¹°ÁúÀÌ Åõ°úÇϱ⠽±´Ù. ±âÀú¸·ÀÌ ÆØÈ­Çϰųª ¹Ðµµ°¡ ³·¾ÆÁö¸é ´Ü¹éÁúÀÌ Åë°úÇÏ¿© ´Ü¹é´¢¸¦ ÀÏÀ¸Å°°í, ±âÀú¸·¿¡ ±Õ¿­-ÆÄ±« µîÀÌ ÀϾ¸é ÀûÇ÷±¸ µîÀÇ Ç÷¾× °íÇü¼ººÐÀÌ Åõ°úÇÏ¿© Ç÷´¢°¡ µÈ´Ù.
¿µ¹® hyaline membrane disease ÇÑ±Û À¯¸®Áú¸·º´
¼³¸í   
  ÇãÆÄ ¼º¼÷µµÀÇ ¹Ì¼÷À¸·Î ÇãÆÄ²Ê¸®¸¦ ÆØÃ¢½Ã۴ ¹°Áú(Ç¥¸éȰ¼ºÁ¦)ÀÌ ºÎÁ·ÇÏ¿© È£Èí°ï¶õÀÌ ÃÊ·¡µÇ´Â º´À¸·Î¼­ ¹Ì¼÷¾Æ¿¡ È£¹ßÇϴµ¥, Ãâ»ý½Ã ÀӽűⰣº¸´Ùµµ ÇãÆÄ ¼º¼÷ Á¤µµ°¡ ´õ °ü¿©µÈ´Ù. ´ÜÀÏ º´À¸·Î¼­´Â »ç¸Á·üÀÌ °¡Àå ³ôÀ¸¸ç(¾à 30%), ½Å»ý¾ÆÀÇ ´ëÇ¥ÀûÀΠº´ÀÌ´Ù. ÀÓ»óÀûÀ¸·Î´Â ¹Ì¼÷¾Æ, »ýÈÄ 6~8½Ã°£³» È£Èí°ï¶õÁõ¼¼ ÃâÇö°ú »ýÈÄ 24~48½Ã°£ÀÇ Áõ»ó ¾ÇÈ­, »ýÈÄ 2~3Àϰ£ ÀΰøÀûÀ¸·Î »ê¼Ò¸¦ °ø±ÞÇÏÁö ¾ÊÀ¸¸é È£ÈíÀ» °è¼Ó½Ãų ¼ö°¡ ¾øÀ¸¸ç Á¡Á¡´õ »ê¼ÒÀÇ °ø±Þ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸ç, µ¿¸ÆÇ÷¾×¼ÓÀÇ »ê¼Ò³óµµ°¡ ³»·Á°¡°í ÀÌ»êȭź¼ÒÀÇ ³óµµ°¡ ³ôÀ¸¸ç, ÈäºÎ ¹æ»ç¼± ¼Ò°ßÀ» ÂüÀÛÇÏ¿© Áø´ÜÇÑ´Ù. È¯¾Æ´Â ¼÷·ÃµÈ °£È£ Àη°ú Ã·´Ü ÀÇ·á Àåºñ°¡ ¼³Ä¡µÈ ½Å»ý¾Æ ÁýÁß Ä¡·á½Ç¿¡¼­ Ä¡·áÇÏ¿©¾ß ÇÑ´Ù. ¿¹ÈĴ Áõ¼¼ÀÇ °æÁß¿¡ µû¶ó ´Ù¸£°í »ç¸Á·üÀº 30~50% µÈ´Ù. ¾î¶² ¾Æ±â¿¡ À־´Â Ä¡·á ÈÄ¿¡ ´«À̳ª ±â°üÁöÇãÆÄ °èÅë¿¡ Àå¾Ö¸¦ ÀÏÀ¸Å°´Â »ê¼ÒÁßµ¶ÁõÀÌ º¸°íµÇ°í ÀÖ´Ù.
¿µ¹® plasma membrane ÇÑ±Û ÇüÁú¸·
¼³¸í   
  ¿øÇüÁú Ç¥¸éÀ» µ¤´Â ¿¯Àº¸·. µÎ²²´Â 5~25¥ìmÀÌ´Ù. ±¤ÇÐÇö¹Ì°æÀ¸·Î´Â °üÂûÇÒ ¼ö ¾øÁö¸¸ ÀüÀÚÇö¹Ì°æÀ¸·Î °üÂûÀÌ °¡´ÉÇÏ´Ù. ¿øÇüÁú¸·ÀÇ ºÐÀÚ±¸Á¶´Â ·¹½ÃƾÀ̳ª ÄÝ·¹½ºÅ×·Ñ µîÀǠǥ¸é È°¼º¹°Áú ºÐÀÚ°¡ 2ºÐÀÚÃþÀ¸·Î ±× Ç¥¸é¿¡ ¹è¿­µÇ¸ç, À̰ÍÀ» °¢ 1ºÐÀÚÃþÀÇ ´Ü¹éÁú ºÐÀÚ°¡ ¾çÂÊ¿¡¼­ »÷µåÀ§Ä¡ÇÑ ´ÜÀ§¸· ±¸Á¶ÀÌ´Ù. ÀüÀÚÇö¹Ì°æÀûÀ¸·Î ÀÌ ´ÜÀ§´Â ¾Ï-¸í-¾ÏÀÇ 3Ãþ(°¢ ¾à 20nm)À¸·Î ±¸º°µÈ´Ù. ¿øÇüÁúÀÇ Åõ°ú¼º¿¡ Áß¿äÇÑ ±¸½ÇÀ» Çϸç, »ý¸®»óŰ¡ º¯Çϸ頱נÅõ°ú¼ºµµ ½Å¼ÓÈ÷ º¯ÇÑ´Ù. ¶Ç, ¼Õ»óÀÌ µÇ¸é ½±°Ô »õ·Î Çü¼ºµÈ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anxiety attack
    ºÒ¾È¹ßÀÛ
  • apneic attack
    ¹«È£Èí¹ßÀÛ
  • asthmatic attack
    õ½Ä¹ßÀÛ
  • attack
    ¹ßÀÛ
  • attack rate
    ¹ßº´·ü
  • breath holding attack
    ¼ûÂü±â¹ßÀÛ, È£ÈíÁßÁö¹ßÀÛ
  • cerebrovascular attack
    ³úÇ÷°ü¹ßÀÛ
  • drop attack
    ¾²·¯Áü¹ßÀÛ, ³Ñ¾îÁü¹ßÀÛ
  • glottal attack
    ¼º¹®¹ßÀÛ
  • panic attack
    °øÈ²¹ßÀÛ
  • recurrent attack
    ¹Ýº¹¹ßÀÛ
  • syncopal attack
    ½Ç½Å¹ßÀÛ
  • secondary attack rate
    ÀÌÂ÷¹ßº´·ü
  • sleep attack
    ¼ö¸é¹ßÀÛ
  • angiotensin converting enzyme inhibitor
    ¾ØÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò¾ïÁ¦Á¦
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inhibitor
    ¾ïÁ¦Á¦
  • selective serotonin reabsorption inhibitor
    ¼±Åü¼·ÎÅä´ÑÀçÈí¼ö¾ïÁ¦Á¦
  • inhibitor substance
    ¾ïÁ¦¹°Áú
  • attack
    ¹ßÀÛ
  • anxiety attack
    ºÒ¾È¹ßÀÛ
  • drop attack
    ³õħ¹ßÀÛ, ³Ñ¾îÁü¹ßÀÛ
  • panic attack
    °øÈ²¹ßÀÛ
  • syncopal attack
    ½Ç½Å¹ßÀÛ
  • transient ischemic attack
    Àϰú¼ºÇãÇ÷¹ßÀÛ
  • attack rate
    ¹ßº´·ü
  • complex
    º¹ÇÕ, º¹ÇÕü, ÄÞÇ÷º½º
  • basal complex
    ¹Ù´Úº¹ÇÕÃþ
  • Golgi's complex
    °ñÁöº¹ÇÕü
  • inferiority complex
    ¿­µîÄÞÇ÷º½º, ¿­µî°¨
  • junctional complex
    ÀÌÀ½ºÎº¹ÇÕü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • attack
    ¹ßÀÛ, °©ÀÛÁõ
  • anxiety attack
    ºÒ¾È¹ßÀÛ
  • apneic attack
    ¹«È£Èí¹ßÀÛ
  • asthmatic attack
    õ½Ä¹ßÀÛ
  • attack rate
    ¹ßº´·ü
  • breath holding attack
    È£ÈíÁßÁö¹ßÀÛ
  • panic attack
    °øÈ²¹ßÀÛ
  • recurrent attack
    ¹Ýº¹¹ßÀÛ
  • sleep attack
    ¼ö¸é¹ßÀÛ
  • syncopal attack
    ½Ç½Å¹ßÀÛ
  • transient ischemic attack
    Àϰú¼ºÇãÇ÷¹ßÀÛ
  • secondary attack rate
    ÀÌÂ÷¹ßº´·ü
  • carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼Ò¾ïÁ¦Á¦
  • clotting inhibitor
    ÀÀ°í¾ïÁ¦Á¦
  • coagulation factor inhibitor
    ÀÀ°íÀÎÀÚ¾ïÁ¦Á¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ÀÀ°í°áÇÕü
  • Stokes-Adams attack
    ½ºÅå ¾Æ´ã½º ¹ßÀÛ
  • TIA=£¾transient ischemic attack
    Àϰú¼º ÇãÇ÷¹ßÀÛ, Àϰú¼º ºóÇ÷¹ßÀÛ.
  • anxiety attack
    ºÒ¾È¹ßÀÛ.
  • gouty attack
    Åëdz¹ßÀÛ.
  • recurrent attack
    ¹Ýº¹Ä§¹ü(ÚãÜÖöÕÛó).
  • recurrent attack
    ¹Ýº¹Ä§¹ü(ÚãÜÖöÕÛó)
  • ACEI : angiotensin converting enzyme inhibitor
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò¾ïÁ¦Á¦(ï®ü½ý£áÈåäð¤ð¥).
  • CAI=£¾carbonic anhydrase inhibitor
    ź»êÅ»¼öÈ¿¼ÒÀúÇØ¾à, ź»êÅ»¼öÈ¿¼ÒÀúÇØ¹°Áú.
  • Inhibitor substance
    ¾ïÁ¦¹°Áú(åäð¤Úªòõ)
  • MAO inhibitor
    ¸ð³ë¾Æ¹Î»êÈ­È¿¼Ò ¾ïÁ¦Á¦.
  • MAO inhibitor
    ¸ð³ë¾Æ¹Î »êÈ­È¿¼Ò ÀúÇØÁ¦.
  • MAO inhibitor(MAOI)
    ´Ü°¡¾Æ¹Î»êÈ­È¿¼Ò¾ïÁ¦Á¦
  • RIMA, see reversible inhibitor of MAO-A
    °¡¿ªÀû ´Ü°¡¾Æ¹Î-A »êÈ­È¿¼Ò¾ïÁ¦Á¦
  • acetylcholinesterase inhibitor
    ¾Æ¼¼Æ®Äݸ°¿¡½ºÅÍ·¹À̽º<¿¡½ºÅ×¶óÁ¦> ¾ïÁ¦Á¦.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • membrane attack complex
    ¸·°ø°Ýº¹ÇÕü
  • membrane attack complex
    ¸·°ø°Ý º¹ÇÕü(دÍô̪ ÜÜùêô÷)
  • membrane attack complex
    ¼¼Æ÷¸·°ø°Ýº¹ÇÕü
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ÀÀ°í°áÇÕü
  • father complex See complex
    ºÎ¼ºÄÞÇ÷º½º(Ý«àõ~)
  • anxiety attack
    ºÒ¾È¹ßÀÛ.
  • asthmatic attack
    õ½Ä¹ßÀÛ(¡­Û¡íÂ).
  • attack
    1. ¹ßÀÛ(Û¡íÂ). 2. °ø°Ý(Íí̪). 3. ¹ß¼º(Û¡á¢).
  • attack of voice
    ¹ß¼º(Û¡á¢).
  • attack rate
    ¹ßº´·ü, ÀÌȯÀ²
  • breath holding attack
    È£ÈíÁßÁö¹ßÀÛ(¡­ñéò­Û¡íÂ).
  • cough attack
    ±âħ¹ßÀÛ(¡­Û¡íÂ).
  • dream anxiety attack
    ²ÞºÒ¾È¹ßÀÛ
  • gouty attack
    Åëdz¹ßÀÛ.
  • panic attack
    °øÈ²¹ßÀÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Basal complex [Basal lamina]
    ¹Ù´Úº¹ÇÕÃþ
    [¿¾ ¿ë¾î] ±âÀúÆÇ
  • Intercellular junctional complex
    º¹ÇÕ¼¼Æ÷»çÀÌ¿¬Á¢
    [¿¾ ¿ë¾î] º¹ÇÕ¼¼Æ÷°£°áÇÕ[¿¬Á¢]
  • Synaptonemal complex
    ¿¬Á¢½Çº¹ÇÕü
    [¿¾ ¿ë¾î] ¿¬Á¢»çº¹ÇÕü
  • Juxtaglomerular complex
    Å丮°çº¹ÇÕü
    [¿¾ ¿ë¾î] »ç±¸Ã¼¹æº¹ÇÕü
  • Golgi complex
    °ñÁöº¹ÇÕü
    [¿¾ ¿ë¾î] °ñÁö±â°ü
  • Golgi complex
    °ñÁöº¹ÇÕü
    [¿¾ ¿ë¾î] °ñÁöº¹ÇÕü
  • Complex follicle
    º¹ÇÕÅÐÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] º¹ÇÕ¸ð³¶
  • Pore complex
    ÇÙ±¸¸Ûº¹ÇÕü
    [¿¾ ¿ë¾î] ÇÙ°øº¹ÇÕü
  • Vestibular wall [Vestibular membrane Reissner`s membrane]
    ¾È¶ã°è´Üº® [¾È¶ã¸·]
    [¿¾ ¿ë¾î] ÀüÁ¤º®[¸·]
  • Oropharyngeal membrane [Buccopharyngeal membrane]
    ÀÔÀεθ·
    [¿¾ ¿ë¾î] ±¸°­Àεθ·
  • (Pupillary membrane)
    (µ¿°ø¸·)
    [¿¾ ¿ë¾î] µ¿°ø¸·
  • Pleuroperitoneal membrane
    °¡½¿¸·º¹¸·¸·
    [¿¾ ¿ë¾î] È丷½É¸·¸·
  • Pleuropericardial membrane
    °¡½¿¸·½ÉÀ帷¸·
    [¿¾ ¿ë¾î] È丷½É¸·¸·
  • Suprapleural membrane
    °¡½¿¸·À§¸·
    [¿¾ ¿ë¾î] È丷»ó¸·
  • Syndesmochorial membrane
    °áÇÕÁ¶Á÷À¶¸ð¸·
    [¿¾ ¿ë¾î] °áÇÕÁ¶Á÷À¶¸ð¸·¼ºÇ÷°£°³À縷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apical complex
    ÷´Üº¹ÇÕü
  • genital complex
    »ý½Äº¹ÇÕü
  • egg membrane
    ³­¸·
  • embryonic membrane
    ÀÚÃæ¸·
  • outer embryophore membrane
    Á¶Ãæ¶õ¿Ü¸·
  • undulating membrane
    ÆÄµ¿¸·
  • vitelline membrane
    ³­È²¸·
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • frontside attack
    Á¤¸é °ø°Ý(ïáØüÍô̪)
  • enzyme-inhibitor complex
    È¿¼Ò-ÀúÇØÁ¦ º¹ÇÕü (ý£áÈîÁúªð¥ÜÜùêô÷)
  • active site-directed irreversible inhibitor
    Ȱ¼º(üÀàõ)ÀÚ¸®ÁöÇâÀû ºÒ°¡¿ªÀúÇØÁ¦(ò¦ú¾îÜÝÕʦæ½îÁúªð¥)
  • Bowman-Birk inhibitor
    "º¸¿ì¸¸-¹÷Å© ÀúÇØÀÚ(îÁúªí­), º¸¿ì¸¸-¹÷Å© ÀúÇØÁ¦(îÁúªð¥)"
  • competitive inhibitor
    °æÇÕÀúÇØÁ¦(ÌæùêîÁúªð¥)
  • heme-controlled inhibitor
    Èû-Á¦¾î(ð¤åÙ) ÀúÇØÁ¦(îÁúªð¥)
  • inhibitor
    ÀúÇØÁ¦(îÁúªð¥)
  • inhibitor constant
    ÀúÇØÁ¦»ó¼ö(îÁúªð¥ßÈâ¦)
  • irreversible inhibitor
    ºñ°¡¿ª ÀúÇØÁ¦(ުʦæ½îÁúªð¥)
  • Kunitz inhibitor
    Äï´ÏÃ÷ ÀúÇØÁ¦(îÁúªð­)
  • mixed-type inhibitor
    È¥ÇÕÇü ÀúÇØÁ¦(ûèùêúþîÁúªð¥)
  • noncompetitive inhibitor
    ºñ°áÇÕ ÀúÇØÁ¦(ު̿ùêîÁúªðº)
  • ovulation inhibitor
    ¹è¶õ ÀúÇØÁ¦(ÛÉÕ°îÁúªð¥)
  • respiratory inhibitor
    È£Èí ÀúÇØÁ¦(îÁúªð¥)
  • reversible inhibitor
    °¡¿ª ÀúÇØÁ¦(îÁúªð¥)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • attack
    ¹ßÀÛ, °ø°Ý, ¹ß¼º
  • inhibitor
    ¾ïÁ¦Á¦, ¾ïÁ¦¹°Áú, ¾ïÁ¦ÀÎÀÚ, ¾ïÁ¦½Å°æ, ¾ïÁ¦À¯ÀüÀÚ, ¾ïÁ¦¾à
  • central renal echo complex
    ½ÅÁ߽ɿ¡ÄÚº¹ÇÕü
  • complex
    ÄÝÇ÷º½º, º¹ÇÕü
  • complex echo pattern
    º¹ÇÕ¿¡ÄÚ¾ç»ó
  • complex potential
    º¹ÇÕÀüÀ§
  • Ghon's complex
    °ïº´º¯±º
  • hyaline membrane disease
    À¯¸®Áú¸·º´
  • membrane
    ¸·
  • mucous membrane
    Á¡¸·
  • periorbital membrane
    ¾È¿Í°ñ¸·
  • primary complex
    Ãʱ⺯ȭ±º
  • serous membrane
    À帷
  • symptom-complex
    ÁõÈıº
  • synovial membrane
    À±È°¸·, Ȱ¸·
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
MAC MacConkey [broth]; major ambulatory category; malignancy-associated changes; maximum allowable conce...
CVA   1) Cardio-Vascular Accident(Attack)
  2) Cerebro-Vascular Accident(Attack);...
BPTI basic pancreatic trypsin inhibitor; basic polyvalent trypsin inhibitor; bovine pancreatic trypsin in...
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MAC Membrane attack complex
MAC membrane attack complex of complement
AR Attack Rate
BHAT Beta-Blocker Heart Attack Trial
TIA Transient Ischaemic Attack
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • anti-inhibitor coagulation complex
    Ç×¾ïÁ¦Á¦ ÀÀ°í °áÇÕü
  • acute gouty attack
    ±Þ¼º Åëdz ¹ßº´
  • attack rate
    ¹ßº´·ü, ÀÌȯÀ²
  • panic attack
    °øÈ² ¹ßÀÛ
  • recurrent attack
    ¹Ýº¹ ħ¹ü
  • C1-esterase inhibitor
    C1-esterase ¾ïÁ¦ ¹°Áú
  • cell wall inhibitor
    ¼¼Æ÷ º® ÇÕ¼º ¾ïÁ¦Á¦
  • coagulation factor inhibitor
    ÀÀ°í ÀÎÀÚ ¾ïÁ¦Á¦
  • collagenase inhibitor
    Äݶó°Ô³ªÁ¦ ¾ïÁ¦ ¹°Áú
  • cyclooxygenase inhibitor
    »çÀÌŬ·Î¿Á½ÃÁö³×ÀÌÁî ¾ïÁ¦Àç
  • dopa decarboxylase inhibitor
    µµÆÄ µ¥Ä«¸£º¹½Ç·¹À̽º ¾ïÁ¦ÀÚ
  • lipoxygenase inhibitor
    ¸®ÆÜ½ÃÁö³×À̽º ¾ïÁ¦Á¦
  • metabolic inhibitor
    ´ë»ç ÀúÇØÁ¦, ´ë»ç ¾ïÁ¦Á¦
  • polymerization inhibitor
    ÁßÇÕ ±ÝÁöÁ¦
    ÁßÇÕ ¹ÝÀÀÀ» ¹æÇØÇϱ⵵ Çϰí, ÁßÁöÇÒ ¼ö ÀÖ´Â ¹°Áú.
  • virus hemagglutination inhibitor
    ¹ÙÀÌ·¯½º ÀûÇ÷±¸ ÀÀÁý¹ÝÀÀ ¾ïÁ¦ ÀÎÀÚ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
membrane attack complex <immunology> A term originally used to refer to the heat labile factor in serum that causes immune cytolysis, the lysis of antibody coated cells and now referring to the entire functionally related system comprising at least 20 distinct serum proteins that is the effector not only of immune cytolysis but also of other biologic functions.
Complement activation occurs by two different sequences, the classic and alternative pathways. The proteins of the classic pathway are termed components of complement and are designated by the symbols C1 through C9.
C1 is a calcium dependent complex of three distinct proteins C1q, C1r and C1s. The proteins of the alternative pathway (collectively referred to as the properdin system) and complement regulatory proteins are known by semisystematic or trivial names. Fragments resulting from proteolytic cleavage of complement proteins are designated with lower case letter suffixes, for example, C3a. Inactivated fragments may be designated with the suffix i, for example C3bi. Activated components or complexes with biological activity are designated by a bar over the symbol for example C1 or C4b, 2a.
The classic pathway is activated by the binding of C1 to classic pathway activators, primarily antigen-antibody complexes containing IgM, IgG1, IgG3, C1q binds to a single IgM molecule or two adjacent IgG molecules.
The alternative pathway can be activated by IgA immune complexes and also by nonimmunologic materials including bacterial endotoxins, microbial polysaccharides and cell walls. Activation of the classic pathway triggers an enzymatic cascade involving C1, C4, C2 and C3, activation of the alternative pathway triggers a cascade involving C3 and factors B, D and P. Both result in the cleavage of C5 and the formation of the membrane attack complex.
Complement activation also results in the formation of many biologically active complement fragments that act as anaphylatoxins, opsonins or chemotactic factors.
(05 Jan 1998)
complement membrane attack complex The assembly of complement plasma glycoproteins c5b, c6, c7, c8, and polymeric c9 as a group on biological membranes. The complex forms transmembrane channels which displace lipid molecules and other constituents, thus disrupting the phospholipid bilayer of target cells leading to cell lysis by osmotic leakage. The formation of the membrane attack complex is the terminal step in the complement cascade.
(12 Dec 1998)
anxiety attack An acute episode of anxiety.
(05 Mar 2000)
attack 1. To fall upon with force; to assail, as with force and arms; to assault. "Attack their lines."
2. To assail with unfriendly speech or writing; to begin a controversy with; to attempt to overthrow or bring into disrepute, by criticism or satire; to censure; as, to attack a man, or his opinions, in a pamphlet.
3. To set to work upon, as upon a task or problem, or some object of labour or investigation.
4. To begin to affect; to begin to act upon, injuriously or destructively; to begin to decompose or waste. "On the fourth of March he was attacked by fever." (Macaulay) "Hydrofluoric acid . . . Attacks the glass." (B. Stewart)
Synonym: To Attack, Assail, Assault, Invade.
These words all denote a violent onset; attack being the generic term, and the others specific forms of attack. To attack is to commence the onset; to assail is to make a sudden and violent attack, or to make repeated attacks; to assault (literally, to leap upon) is to attack physically by a had-to-hand approach or by unlawful and insulting violence; to invade is to enter by force on what belongs to another. Thus, a person may attack by offering violence of any kind; he may assail by means of missile weapons; he may assault by direct personal violence; a king may invade by marching an army into a country. Figuratively, we may say, men attack with argument or satire; they assail with abuse or reproaches; they may be assaulted by severe temptations; the rights of the people may be invaded by the encroachments of the crown.
Origin: F. Attaquer, orig. Another form of attacher to attack: cf. It. Attacare to fasten, attack. See Attach, Tack a small nail.
1. The act of attacking, or falling on with force or violence; an onset; an assault; opposed to defense.
2. An assault upon one's feelings or reputation with unfriendly or bitter words.
3. A setting to work upon some task, etc.
4. An access of disease; a fit of sickness.
5. The beginning of corrosive, decomposing, or destructive action, by a chemical agent.
Origin: Cf. F. Attaque.
Source: Websters Dictionary
(01 Mar 1998)
attack rate A cumulative incidence rate used for particular groups observed for limited periods under special circumstances, such as during an epidemic.
(05 Mar 2000)
vagal attack <syndrome> Syndrome consisting of palpitation, chest pain, respiratory difficulties, and disturbances in gastric motility; once attributed to vagal stimulation, now considered psychogenic (anxiety neurosis).
Synonym: vagal attack, vasovagal attack.
(05 Mar 2000)
vasovagal attack <syndrome> Syndrome consisting of palpitation, chest pain, respiratory difficulties, and disturbances in gastric motility; once attributed to vagal stimulation, now considered psychogenic (anxiety neurosis).
Synonym: vagal attack, vasovagal attack.
(05 Mar 2000)
heart attack This refers to that damage that occurs to the heart when one of the coronary arteries becomes occluded.
Common symptoms include crushing, substernal chest pain that may radiate to the jaw or the left arm, accompanied by nausea, sweating and shortness of breath. Fainting is a more uncommon presentation.
(27 Sep 1997)
salaam attack In infants, a drop of the head on the chest due to loss of tone in the neck muscles as in epilepsia nutans, or to tonic spasm of anterior neck muscles as in West's syndrome, in adults, a nodding of the head from clonic spasm's of the sternomastoid muscles.
Synonym: salaam attack, salaam spasm, spasmus nutans.
(05 Mar 2000)
transient ischaemic attack A transient ischaemic attack is a temporary paralysis, numbness, speech difficulty or other neurologic symptoms that start suddenly and recovers within 24 hours (typically resolve over several hours).
See: neurologic symptoms, stroke.
Acronym: TIA
(26 Mar 1998)
transient ischemic attack A sudden focal loss of neurological function with complete recovery usually within 24 hours; caused by a brief period of inadequate perfusion in a portion of the territory of the carotid or vertebral basilar arteries.
(05 Mar 2000)
uncinate attack A form of psychomotor epilepsy or complex partial seizure initiated by a dreamy state and hallucinations of smell and taste, usually the result of a medial temporal lesion.
Synonym: uncinate attack.
(05 Mar 2000)
a1-trypsin inhibitor A glycoprotein that is the major protease inhibitor of human serum, is synthesised in the liver, and is genetically polymorphic due to the presence of over 20 alleles; individuals appropriately homozygous are deficient in a1-trypsin and are predisposed to pulmonary emphysema and juvenile hepatic cirrhosis because of alterations in the amino acid and sialic acid components of the glycoprotein. A1-Antitrypsin also inhibits thrombin.
Synonym: a1-trypsin inhibitor, human a1-proteinase inhibitor.
(05 Mar 2000)
ACE inhibitor <pharmacology> A group of antihypertensive medications that work by inhibiting an enzyme (angiotensin-converting enzyme) that is important in the regulation of blood pressure.
Studies have also indicated that it may help prevent or slow the progression of kidney disease in patients with diabetes.
Examples include: captopril, ramipril, enalapril, losartan potassium, bepridil and lisinopril.
(12 Mar 1998)
aldose reductase inhibitor <pharmacology> A class of drugs being studied as a way to prevent eye and nerve damage in people with diabetes.
Aldose reductase is an enzyme that is normally present in the eye and in many other parts of the body. It helps change glucose (sugar) into a sugar alcohol called sorbitol. Too much sorbitol trapped in eye and nerve cells can damage these cells, leading to retinopathy and neuropathy.
Drugs that prevent or slow (inhibit) the action of aldose reductase are being studied as a way to prevent or delay these complications of diabetes.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • inhibitor
    ¾ïÁ¦ÀÚ(¹°);¹ÝÀÀ¾ïÁ¦Á¦
  • cell membrane
    ¼¼Æ÷¸·;¿øÇüÁú¸·;=CELL WALL
  • membrane
    ¾ãÀº ¸·;¸·ÇÇ;¾çÇÇÁö;¹®¼­ÀÇ ÇÑÀå
  • mucous membrane
    Á¡¸·
  • nictitating membrane
    ¼ø¸·;(»õ ¾Ç¾îµîÀÇ ´«²¨Ç® ¾ÈÂÊ¿¡ ÀÖ´Â Á¦ 3ÀÇ ´«²¨Ç®)
  • nuclear membrane
    (»ý)ÇÙ¸·
  • tympanic membrane
    °í¸·
  • attack
    À» °ø°ÝÇÏ´Ù
  • air attack
    °ø½À
  • attack
    °ø°ÝÇÏ´Ù;½À°ÝÇÏ´Ù;ħ¹üÇÏ´Ù;Âø¼öÇÏ´Ù
  • gas attack
    µ¶°¡½º °ø°Ý
  • general attack
    ÃѰø°Ý
  • heart attack
    =HEART FAILURE
  • surprise attack
    ±â½À
  • complex
    º¹ÀâÇÑ,º¹ÇÕÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á